drugset / Trial / NCT00707538

A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress

NCT00707538 ↗

Phase 1 Completed 12 enrolled Lantheus Medical Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158

Timeline

Start
2008-06
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS747158 Diagnostic / imaging agent 407 mbq Intravenous

Indications

No indication recorded.